Literature DB >> 24851832

The morphological growth patterns of colorectal liver metastases are prognostic for overall survival.

Kåre Nielsen1, Hans C Rolff2, Rikke L Eefsen3, Ben Vainer1.   

Abstract

Colorectal metastases in the liver grow according to three histological patterns: a pushing pattern, a replacement pattern, and a desmoplastic pattern. The objective of the current study was to explore the prognostic significance of these three growth patterns for survival. The study included 217 consecutive patients, liver resected between 2007 and 2011 due to hepatic metastases from colorectal adenocarcinoma. The growth patterns were assessed on archival hematoxylin and eosin-stained tissue sections. In 150 metastases, the density of the immune cell infiltrate at the tumor periphery was judged by a semi-quantitative method. The prevalence of the pushing-type, the desmoplastic-type, and the replacement-type was 33%, 32%, and 11%, respectively; 24% of the metastases displayed a mixed pattern. Kaplan-Meier analysis and Cox regression demonstrated a prognostic significance of the growth patterns (P=0.0006, log-rank test), as the replacement pattern appeared as an independent predictor of poor overall survival. For patients with replacement growth, the hazard of death was 2-2.5 times higher than for patients with pushing growth (P=0.004, cox regression) or mixed growth (P=0.01), and nearly four times higher than for patients with desmoplastic growth (P<0.0001). The negative prognostic effect of the replacement growth pattern was even more pronounced after adjusting for tumor size. Desmoplastic growth corresponded with small tumor size, dense lymphocytic infiltration and a more favorable prognosis. Eventually, the growth patterns may contribute to a histology-based prognostic biomarker for patients with colorectal liver metastases.

Entities:  

Mesh:

Year:  2014        PMID: 24851832     DOI: 10.1038/modpathol.2014.4

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  37 in total

1.  Growth pattern of colorectal liver metastasis as a marker of recurrence risk.

Authors:  R L Eefsen; P B Vermeulen; I J Christensen; O D Laerum; M B Mogensen; H C Rolff; G G Van den Eynden; G Høyer-Hansen; K Osterlind; B Vainer; M Illemann
Journal:  Clin Exp Metastasis       Date:  2015-03-31       Impact factor: 5.150

2.  Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.

Authors:  Albert Liao; Pardeep Mittal; David H Lawson; Jenny J Yang; Eszter Szalai; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2017-11-06       Impact factor: 12.079

3.  RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.

Authors:  Kristoffer Watten Brudvik; Yoshihiro Mise; Michael Hsiang Chung; Yun Shin Chun; Scott E Kopetz; Guillaume Passot; Claudius Conrad; Dipen M Maru; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2016-03-25       Impact factor: 5.344

4.  Histopathological growth patterns and positive margins after resection of colorectal liver metastases.

Authors:  Pieter M H Nierop; Diederik J Höppener; Eric P van der Stok; Boris Galjart; Florian E Buisman; Vinod P Balachandran; William R Jarnagin; T Peter Kingham; Peter J Allen; Jinru Shia; Peter B Vermeulen; Bas Groot Koerkamp; Dirk J Grünhagen; Cornelis Verhoef; Michael I D'Angelica
Journal:  HPB (Oxford)       Date:  2019-11-15       Impact factor: 3.647

5.  mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy.

Authors:  E P van der Stok; M Smid; A M Sieuwerts; P B Vermeulen; S Sleijfer; N Ayez; D J Grünhagen; J W M Martens; C Verhoef
Journal:  Mol Oncol       Date:  2016-09-20       Impact factor: 6.603

6.  Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?

Authors:  Eran Sadot; Bas Groot Koerkamp; Julie N Leal; Jinru Shia; Mithat Gonen; Peter J Allen; Ronald P DeMatteo; T Peter Kingham; Nancy Kemeny; Leslie H Blumgart; William R Jarnagin; Michael I DʼAngelica
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

7.  Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy.

Authors:  R L Eefsen; L Engelholm; W Alpizar-Alpizar; G G E Van den Eynden; P B Vermeulen; I J Christensen; O D Laerum; H C Rolff; G Høyer-Hansen; B Vainer; K Osterlind; M Illemann
Journal:  Cancer Microenviron       Date:  2015-08-14

8.  Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.

Authors:  Georgios Antonios Margonis; Kazunari Sasaki; Yuhree Kim; Mario Samaha; Stefan Buettner; Neda Amini; Efstathios Antoniou; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2016-07-06       Impact factor: 3.452

Review 9.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

10.  Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern.

Authors:  Sébastien Tabariès; Matthew G Annis; Anthoula Lazaris; Stephanie K Petrillo; Jennifer Huxham; Amri Abdellatif; Vincent Palmieri; Jaclyn Chabot; Radia M Johnson; Steven Van Laere; Cornelis Verhoef; Yasmina Hachem; Sara Yumeen; Nicholas Meti; Atilla Omeroglu; Gulbeyaz Altinel; Zu-Hua Gao; Alan S L Yu; Dirk J Grünhagen; Peter Vermeulen; Peter Metrakos; Peter M Siegel
Journal:  Commun Biol       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.